Neurology

From stroke to neurodegeneration — the science and its clinical impact.

Vigabatrin Label Warns of Permanent Vision Loss and Restricted Access

Updated vigabatrin labeling reinforces permanent vision loss risk, REMS restrictions, infantile spasm dosing, renal adjustment, and key safety warnings.

By Dr. A. Manasa, MBBS · Oct 19, 2026 · 5 min read

Neurology·Nat Immunol

Astrocytes present antigen and drive TH17 autoimmunity in multiple sclerosis

Astrocytes with CD40 and MHC-II acted as antigen-presenting cells in CNS autoimmunity, amplifying TH17 cells and worsening EAE…

Oct 19, 2026

Neurology·Nat Rev Neuro

MRI Guidance Refines Diagnosis in AQP4+ NMOSD and MOGAD

MAGNIMS guidance standardizes MRI use in AQP4+ NMOSD and MOGAD, improving diagnosis, relapse assessment, and follow-up care.

Oct 19, 2026

Neurology·Nat Rev Neuro

Lysosomal dysfunction emerges as a central driver in neurodegeneration

A Nature Reviews Neurology review links lysosomal defects to Parkinson disease, Alzheimer disease, FTD and ALS, with drug…

Oct 19, 2026

Neurology·Nat Rev Neuro

Stroke biomarker roadmap aims to track injury, inflammation and recovery

Nature Reviews Neurology outlines a six-phase roadmap for stroke biomarkers that could track injury, inflammation, metabolism and gut…

Oct 19, 2026

Neurology·Nat Rev Neuro

Multiple sclerosis course descriptors face push for biologic reclassification

An International Advisory Committee roadmap argues current MS course labels miss biology and calls for a dynamic, mechanism-based…

Oct 19, 2026

Neurology·Med News Today

Artificial sweeteners linked to brain aging in Neurology study

A Neurology study linked several artificial sweeteners to faster memory and thinking decline, raising questions about long-term brain…

Oct 19, 2026

Neurology·BBC Dental

Batten disease fundraiser tops target for Lancashire girl’s wheelchair van

A Lancashire family’s appeal for a wheelchair-accessible van for a seven-year-old with Batten disease has passed its £10,000…

Oct 19, 2026

Neurology·BBC Dental

Omaveloxolone access fight intensifies for teen with Friedrich’s ataxia

A teenager with Friedrich's ataxia is seeking NHS access to omaveloxolone as political pressure builds around the stalled…

Oct 19, 2026

Neurology·BBC Dental

Huntington’s disease family speaks after first gene therapy breakthrough

A Jersey woman with Huntington’s disease describes daily decline, family strain and renewed hope after the first gene…

Oct 19, 2026

Neurology

From stroke to neurodegeneration — the science and its clinical impact.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.